ResearcherPhenomenome Discoveries (Canada)No recent work listed
Morito Monden
Matched on OpenAlex author ID A5108403721. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper
Papers 3
- Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. Co-author DOI 10.1097/mpa.0000000000000680↗
- Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. Co-author DOI 10.1186/1471-2407-13-416↗
- [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer]. Last author PMID 21566438↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuichiro Doki · 3 shared papers, 2011–2016 · strength 0.11
- Paper Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study. DOI 10.1097/mpa.0000000000000680↗
- Paper Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. DOI 10.1186/1471-2407-13-416↗
- Paper [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancre… PMID 21566438↗
- Shawn A. Ritchie · 2 shared papers, 2013–2016 · strength 0.08
- Hidetoshi Eguchi · 2 shared papers, 2013–2016 · strength 0.08
- Hirofumi Akita · 2 shared papers, 2013–2016 · strength 0.08
- Hiroaki Nagano · 2 shared papers, 2013–2016 · strength 0.08
- Ichiro Takemasa · 2 shared papers, 2013–2016 · strength 0.08
- Dayan B. Goodenowe · 2 shared papers, 2013–2016 · strength 0.08
- Shoji Nakamori · 1 shared paper, 2011 · strength 0.02
- Masaki Mori · 1 shared paper, 2011 · strength 0.02
- Takashi Shibata · 1 shared paper, 2011 · strength 0.02
- Yutaka Takeda · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.